EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Researchers have developed a working prototype of a PCR test for monkeypox that provides accurate, easy-to-read results The test works with a compact, portable system developed for COVID-19 ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

Lateral flow tests (LFTs) are quick and easy to take at home, giving a result within 20-30 minutes. They look for proteins on the surface of the virus, which are easily detected. However, they have a ...

The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

Rite Aid is joining forces with Quest Diagnostics to provide access to molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and ...

Researchers have built an RT-PCR platform that gives results in 23 minutes that match the longer laboratory-based tests -- faster than other PCR tests on the market. It can be adapted to test for a ...

Please provide your email address to receive an email when new articles are posted on . The FDA has issued an emergency use authorization to Abbott Molecular for its real-time PCR test for monkeypox ...

The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...

The fraction, volume and frequency of the patient sample collection; DNA extraction and purification procedures, which greatly influence the performance of the downstream molecular tests. It is worth ...